Seabra Lab

Advancing retinal disease research by unraveling underlying molecular mechanisms and developing cost-effective gene therapies using mRNA and nanoparticles.

[CureCHM @curechm]

Choroideremia Research Foundation Announces Six New Global Grants to Accelerate Vision Science

#CureCHM #VisionResearch #CRF

https://t.co/0VtwHLswwD

[Seabra Lab @MSeabraLab]

We are happy to share our latest publication!
https://t.co/ASvI8MionV

#benbedphar
#agerelatedmaculardegeneration
#retinaresearch
#eyeresearch

[Seabra Lab @MSeabraLab]

🌟 New Year, New Website! 🌟
We’re excited to kick off 2025 with a fresh start – the Ocular Low-Cost Gene Therapy Lab website is now live! Explore our projects, meet the team, stay updated with lab news, and check out our publications. Visit us at https://t.co/KAZQD8BvnO

[Seabra Lab @MSeabraLab]

Miguel Seabra will be speaking at the 4th mRNA-Based Therapeutics Summit Europe (28th-30th Jan 2025, Frankfurt, Germany)! Don’t miss this opportunity to explore the latest advances in mRNA therapeutics. Read more: https://t.co/QeCyU5zhiD
#mRNA #GeneTherapy

[Seabra Lab @MSeabraLab]

Miguel Seabra won the NOVA Research Impact Narratives Challenge 2024! 🏆
His narrative, "Twenty years from Gene Identification to Therapeutic Intervention," showcases over two decades of pioneering work in gene therapy for retinal diseases. Read more: https://t.co/U33HrOv03I

[Luisa Lemos @mluisosca]

Happy to present our last research work on Ocular Gene Therapy at #ARVO2024, Seattle, WA! @MSeabraLab
Thanks to @ChampalimaudF @curechm for their funding support.
#Choroideremia #Inheritedretinaldiseases

[Seabra Lab @MSeabraLab]

Excited to share our latest research on isogenic stem cell models for Choroideremia, featured on the cover of Stem Cells and Development! 🌱🧬 Discover their potential for studying RPE degeneration mechanisms. Read the full paper: https://t.co/5JpytFYEwD #ChoroideremiaResearch

[Seabra Lab @MSeabraLab]

More exciting news! Last week, Miguel Seabra was presented with a Career Award by the Portuguese Biochemical Society, during the XXII National Congress of Biochemistry at the University of Aveiro (Portugal).
Cheers to Miguel! 🎉

[Seabra Lab @MSeabraLab]

Our Group Leader, Miguel Seabra, has been distinguished with the European Society for Pigment Cell Research (ESPCR) Award at the 25th annual meeting in Marseille. This honor recognizes his significant contributions to skin pigmentation research.
Congratulations, Miguel! 👏

[Trends in Molecular Medicine @TrendsMolecMed]

ONLINE NOW: Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases https://t.co/icDfQE9iY0

[CureCHM @curechm]

France Choroïdérémie Symposium 2024 welcoming 🤩 In this photo Eric Hartman from CRF, Dr. Miguel Seabra @MSeabraLab & the van Renselaar Family.


[CureCHM @curechm]

France #Choroideremia symposium. Thank you to all the brilliant minds from all over the world discussing CHM. Taking another step forward 🙏🏻🙏🏻@sharmaruchi29 @JKJolly4 @Vision_INM @elfridedebaere @MaliaEdwardsLab @MariyaMoosajee @MiguelSeabra6 @eyeMacLaren @rharbottle @mluisosca

[Seabra Lab @MSeabraLab]

We are very happy and thankful with this award!

[CureCHM @curechm]

Throssell-Hillier #Choroidermia award winners announced!

Congratulations to Dr.Miguel Seabra Dr.Pedro Antas, Portugal: CRISPR-Based Gene Editing for CHM. ⁦@MiguelSeabra6⁩
⁦@MSeabraLab⁩ https://t.co/BdMsGLmJXR

[Seabra Lab @MSeabraLab]

A não perder

[90 Segundos de Ciência @90segundosPT]

.@TenreiroSandra da @nova_medschool está a desenvolver modelos de retina em laboratório que podem ser usados para estudar os mecanismos moleculares que levam ao desenvolvimento da retinopatia diabética.

https://t.co/0L19lAWJHC

#90SegundosCiência

[NOVA Medical School, Faculdade de Ciências Médicas @nova_medschool]

📍Applications for the 7th Edition of NBR (NOVA Biomedical Research) start on March 15!

Our #MSc programme will equip you with the core skills for an outstanding career in #Biomedical research.

📅 Deadline for applications: 15.03-30.04.2023

More info 👇
https://t.co/exH35PufPJ

[LVPEI @lvprasadeye]

LVPEI recognised as a top global institute
#HappyToShare #recognition #Ophthalmology #Healthcare #LVPEI #SoThatAllMaySee

[Seabra Lab @MSeabraLab]

Today is #rareDiseaseday! We want to express out support for all patients and families who are affected by rare diseases.
In our Lab, we are dedicated to study #choroideremia, a rare chorioretinal dystrophy that causes vision loss.
@curechm
@ChampalimaudF
@nova_medschool

[Mathieu Ferron @Mathieu_Ferron]

My humble opinion, is that this is the result of half-century of peer review...

[Seabra Lab @MSeabraLab]

Our work on the media
https://t.co/IhrfPP9BzH

[Seabra Lab @MSeabraLab]

Rita Coelho defended her MSc thesis:"Characterization of cellular organelles and the endolysosomal pathway in #choroideremia patient cells" @nova_medschool, under Mafalda Silva supervision. For the great discussion, we counted on Clare Futter @UCLeye